menu search

Us judge blasted for secrecy in google antitrust case after presiding over jan. 6 trials

Judge Amit P. Mehta is solely responsible for deciding if Google has broken the law in its quest to maintain dominance....

September 29, 2023, 6:16 pm

Economic institutions lowered their forecasts for german gdp. oil updates highs again

By JustMarkets At yesterday’s stock market close, the Dow Jones Index (US30) decreased by 0.20%, while the S&P 500 Index (US500) added 0.02%. The NA...

September 28, 2023, 12:10 pm

Nxu launches revenue-generating ev charging field trials in celebration of national drive electric week

Nxu One Megawatt+ Charging System is Open to the Public with $1 Charging Promotion MESA, Ariz., Sept. 28, 2023 (GLOBE NEWSWIRE) — Nxu Inc., (NASDAQ:...

September 28, 2023, 10:30 am

Aclaris therapeutics: the many lives of this biopharmaceutical developer

Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...

September 28, 2023, 7:18 am

Moonlake immunotherapeutics is now thoroughly de-risked

MoonLake Immunotherapeutics has seen success in the last 5 months after positive data from a phase 2 trial of sonelokimab in hidradenitis suppurativa....

September 27, 2023, 8:00 pm

Standex to present at william blair's what's next for industrials conference

SALEM, N.H. , Sept. 27, 2023 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) announced today that David Dunbar, President & CEO, and Ade...

September 27, 2023, 5:26 pm

Intraoperative radiation therapy systems market poised for a 7.7% cagr surge, reaching us$ 124.7 million by 2033 | future market insights inc.

Intraoperative Radiation Therapy Systems: Advancing Cancer Care. IORT’s precision, clinical trials an...

September 27, 2023, 2:30 pm

Is spdr s&p homebuilders etf (xhb) a strong etf right now?

Designed to provide broad exposure to the Industrials ETFs category of the market, the SPDR S&P Homebui...

September 27, 2023, 7:31 am

Costco share fall following results, while cardiff oncology and millerknoll shares soar, and more moving stocks

Cardiff Oncology Inc. CRDF, +0.62% shares surged 32% on favorable data from two cancer drug trials...

September 27, 2023, 5:56 am

Immunovant: immune boost, from clinical trials to an aggressive bullish stock

Although Immunovant's stock has rallied around 100% since January, recent data on its therapeutic candidate, IMVT-1402, has further bolstered confiden...

September 27, 2023, 5:30 am

: corrected: dow closes below 200-day moving average, as long-term treasury yields climb

This article has been updated to reflect the correct date when the Dow Industrials last fell below its ...

September 26, 2023, 8:58 pm

Scynexis: from fungal to bungle, the brexafemme recall and a slippery slope (rating downgrade)

We downgrade Scynexis to a sell rating following the voluntary recall of antifungal pill, Brexafemme. Historical precedence suggests that manufacturin...

September 26, 2023, 7:54 pm

Biogen inc. (biib) management presents at decentralized clinical trials in focus conference (transcript)

Biogen Inc. (NASDAQ:BIIB ) Decentralized Clinical trials in Focus Conference September 26, 2023 10:00 A...

September 26, 2023, 5:17 pm

Summit therapeutics: not for retail investors

Summit Therapeutics Inc., backed by biotech billionaire Bob Duggan, has transitioned from developing antibiotics to becoming an oncology therapeutics ...

September 26, 2023, 3:00 pm

4d molecular therapeutics: some failures, a few key successes

4D Molecular Therapeutics, Inc. has faced setbacks, with the FDA placing a clinical hold on its Fabry Disease program due to serious kidney conditions...

September 25, 2023, 12:19 pm

Littelfuse: e-mobility and m&a could bring substantial market attention

Littelfuse is a global industrial technology company that may benefit from investment trends in sustainability, connectivity, and security. The compan...

September 25, 2023, 7:52 am

Should you invest in the spdr s&p homebuilders etf (xhb)?

Looking for broad exposure to the Industrials - Engineering and Construction segment of the equity mark...

September 25, 2023, 7:31 am

Aldeyra:upcoming pdufa, strong nda, long pipeline, decent cash

Aldeyra is a late-stage company developing therapies for immune-mediated diseases, with a focus on dry eye disease and allergic conjunctivitis. Their ...

September 22, 2023, 7:44 pm

Merck and eisai say two lung-cancer trials failed to meet their main goals

Merck and Japanese partner Eisai said Friday that two late-stage trials of a treatment for a certain ty...

September 22, 2023, 7:31 am

Prothena: switching from 'hold' to 'buy' on lead alzheimer's drug promise

Prothena Corporation is a protein dysregulation specialist with a focus on developing drugs for Alzheimer's disease. The company's lead candidate, PRX...

September 21, 2023, 1:39 pm


Search within

Pages Search Results: